Profund Advisors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Buy |
19,805
+3,757
| +23% | +$200K | 0.04% | 288 |
|
|
2025
Q1 | $650K | Buy |
16,048
+1,196
| +8% | +$48.4K | 0.03% | 404 |
|
|
2024
Q4 | $413K | Sell |
14,852
-3,667
| -20% | -$102K | 0.02% | 608 |
|
|
2024
Q3 | $531K | Sell |
18,519
-4,319
| -19% | -$124K | 0.02% | 510 |
|
|
2024
Q2 | $536K | Sell |
22,838
-23,032
| -50% | -$540K | 0.02% | 480 |
|
|
2024
Q1 | $1.16M | Sell |
45,870
-26,674
| -37% | -$674K | 0.05% | 324 |
|
|
2023
Q4 | $1.69M | Buy |
72,544
+41,322
| +132% | +$965K | 0.07% | 205 |
|
|
2023
Q3 | $1.58M | Buy |
31,222
+2,228
| +8% | +$113K | 0.09% | 180 |
|
|
2023
Q2 | $1.35M | Sell |
28,994
-1,584
| -5% | -$74K | 0.07% | 240 |
|
|
2023
Q1 | $1.17M | Buy |
+30,578
| New | +$1.17M | 0.07% | 265 |
|